Citation: | WEI Yu. Han Shuren's Clinical Experience of Treating Pulmonary Interstitial Fibrosis with Buyang Huanwu Decoction[J]. Journal of Nanjing University of traditional Chinese Medicine, 2014, 30(5): 486-488. |
[1] |
朱元珏.慢性肺间质病[J].现代呼吸病学,1996, 8(1):714-724.
|
[2] |
Zhu YJ. Chronic interstitial lung disease[J]. Mod Respirol, 1996, 8(1): 714-724.
|
[3] |
蔡后荣.2011年特发性肺间质纤维化诊断和治疗循证新指南解读[J].中国呼吸与危重监护杂志,2011(10):313-316.
|
[4] |
Fu NY. Understanding to guidelines for diopathic pulmonary fibrosis: diagnosis and treatment of 2011[J]. Chin J Respir Crit Care Med, 2011(10): 313-316.
|
[5] |
黄帝内经[M].北京:人民卫生出版社,2012:84.
|
[6] |
The Yellow Emperor's Inner Classic[M].Beijing:People's medical publishing house, 2012:84.
|
[7] |
张仲景.金匮要略[M].北京:学苑出版社,2012:39.
|
[8] |
Zhang ZJ.Jinkui Yaolve [M].Beijing: Academy press, 2012:39.
|
[9] |
程文囿.医述[M].合肥:安徽人民出版社,1990:681.
|
[10] |
Cheng WY. Account of medicine[M]. Hefei: Anhui people's publishing house,1990:681.
|
[11] |
陈士铎.辨证录[M].北京:人民卫生出版社,1989:91.
|
[12] |
Chen SD. Differentiation of symptoms and signs[M]. Beijing:People's medical publishing house, 1989:91.
|
[13] |
张平,李杰平,于小华,等.黄芪甲甙对实验性肺纤维化大鼠Cathepsin B表达的影响[J].现代生物医学进展,2007, 7(6):860-862.
|
[14] |
Zhang P, Li JP, Yu XH, et al. Effect of astragalaside on cathepsin B expression in the lung of rats with experimental pulmonary fibrosis[J]. Progr Mod Biomed, 2007, 7(6): 860-862.
|
[15] |
江振国.川芎嗪注射液治疗肺间质纤维化临床观察[J].中国中医药信息杂志,2013, 20(9):78-79.
|
[16] |
Jiang ZG. Clinical observation of Ligustrazine Injection in the treatment of pulmonary interstitial fibrosis[J]. Chin J Inform Tradit Chin Med, 2013, 20(9): 78-79.
|
[17] |
范京国,周东民.补阳还五汤临床应用研究进展[J].甘肃中医,2002, 15(2):81-82.
|
[18] |
Fan JG, Zhou DM. Study progress in clinical application of Buyang Huanwu Decoction[J]. Gansu J Tradit Chin Med , 2002, 15(2): 81-82.
|